Stock Fundamentals

Company Information

Company Name
Purple Biotech
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US74638P1093
CIK: 0001614744
Currency: USD
Full Time Employees: 10
Phone: 972 3 933 3121
Fiscal Year End: December
IPO Date: Nov 20, 2015
Description:

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and CAPTN-3 - IM1240 and IM1305, multi-valent antibody designed to activate anti-tumoral immune response against TAA positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.

Address:

4 Oppenheimer Street, Rehovot, Israel, 7670104

Directors & Officers

Name Title Year Born
Mr. Gil Efron CPA, M.A. CEO & Director 1966
Mr. Shai Lankry CPA, M.B.A. Chief Financial Officer 1976
Dr. Michael Schickler Ph.D. Head of Clinical & Regulatory Affairs 1958

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Susquehanna International Group, LLP 53.40K Mar 31, 2026 5.73% $0.00 13.68%
SmartHarvest Portfolios, LLC 18.13K Mar 31, 2026 1.94% $0.03 282.02%
Two Sigma Advisers, LLC 14.70K Dec 31, 2025 0.16% $0.00 0.00%
BNP Paribas Arbitrage, SA 1.96K Mar 31, 2026 0.21% $0.00 -7.12%
Rhumbline Advisers 710.00 Mar 31, 2026 0.08% $0.00 -3.92%
SIMPLEX TRADING, LLC 597.00 Mar 31, 2026 0.06% $0.00 -35.32%
Morgan Stanley - Brokerage Accounts 578.00 Mar 31, 2026 0.06% $0.00 -5.09%
Group One Trading, LP 294.00 Dec 31, 2025 0.00% $0.00 0.00%
GAMMA Investing LLC 108.00 Mar 31, 2026 0.01% $0.00 -61.97%
UBS Group AG 99.00 Mar 31, 2026 0.01% $0.00 -68.06%
SBI Securities Co Ltd 31.00 Mar 31, 2026 0.00% $0.00 -3.13%
Global Retirement Partners, LLC. 16.00 Dec 31, 2025 0.00% $0.00 0.00%
Royal Bank of Canada 10.00 Mar 31, 2026 0.00% $0.00 -9.09%
Advisory Services Network, LLC 9.00 Mar 31, 2026 0.00% $0.00 0.00%
Northwestern Mutual Wealth Management Co 8.00 Mar 31, 2026 0.00% $0.00 0.00%
JONES FINANCIAL COMPANIES LLLP 5.00 Mar 31, 2026 0.00% $0.00 0.00%
Danske Bank A/S. 4.00 Mar 31, 2026 0.00% $0.00 0.00%
Tradewinds Capital Management, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Citadel Advisors Llc 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Two Sigma Investments LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 932.27K
Shares Float: 925.48K
% Insiders: 597.20%
% Institutions: 1,049.50%
Short % Float: 5.27%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 633.00 0.04% ▲ 0.00% Oct 31, 2024

Valuation Metrics

Enterprise Value: $46.95K
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.47M
EBITDA: $-7.80M
P/E Ratio: $0.00
Book Value: $10.00
Earnings/Share: $3.23K
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -19.55%
ROE (TTM): -123.35%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.27x 0.03x 0.45x -704.05x -0.01x
2024-12-31 2.23x 0.01x 0.11x -24.62x -0.05x
2023-12-31 2.20x 0.01x 0.23x -10.21x -0.01x
2022-12-31 4.71x 0.00x 0.14x -337.36x -0.01x
2021-12-31 11.41x 0.00x 0.07x -84.59x -0.01x
2020-12-31 19.14x 0.00x 0.05x -236.41x -0.01x
2019-12-31 2.34x 0.02x 0.26x -39.54x -0.03x
2018-12-31 2.57x 0.00x 0.25x -869.56x 0.00x
2017-12-31 1.96x 0.24x 0.39x -460.23x -0.14x
2016-12-31 11.70x 0.00x 0.10x -1,197.17x 0.00x
2015-12-31 9.02x 0.00x 0.13x -1,356.33x 0.00x
2014-12-31 1.78x 0.38x 0.56x -246.71x -0.06x
2013-12-31 0.25x -0.95x 4.04x -53.19x -0.75x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PPBT.US!